Special items: Ovarian Cancer and Us blog best viewed in Firefox

Saturday, May 21, 2011

abstract: Trastuzumab and pertuzumab produce changes in morphology and estrogen receptor signaling in ovarian cancer xenografts revealing new treatment strategies.


No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.